Javier Velasco-Alvarez

Chief Executive Officer of Neol Bio holds a PhD in Industrial Biotechnology (Universidad de León) and MD in Food Sciences and Technology (Universidad de León) and a Master in Innovation Management (Universidad Politécnica de Madrid). Managing Director of Neuron Bio (2005-2012), contributing to its incorporation to the MAB (Spanish Alternative Stock Exchange). Previously, Mr. Velasco leaded the Biotechnology Department of Puleva Biotech, S.A. and was researcher in GlaxoSmithKline and Antibioticos, S.A. He is an expert in technologies valuation and biotechnological Companies, as well as in the management of intellectual property portfolios. He is Member of the Board of the Spanish Technology Platform for Sustainable Chemistry (SUSCHEM-ES) coordinating the working group on “Industrial Biotech & Biorefineries”. He is also Member of the Board of Directors of the Spanish Association of BioIndustries (ASEBIO) where he has been named Chairman of the Industrial Biotechnology working group and coordinating the BioEconomy Group. He is also Member of the Board of the Spanish Association of Scientific Entrepreneurs. He is co-author of more than 30 scientific publications and 17 patent families related to Industrial Biotechnology.